# FDA 483 - Center for Translational Medicine - July 11, 2025

Source: https://www.keypedia.com/records/483/center-for-translational-medicine/f7bac46c-b8e0-4980-89f0-9442c1f9a8c7

> FDA 483 for Center for Translational Medicine on July 11, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Center for Translational Medicine
- Inspection Date: 2025-07-11
- Product Type: other
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Center for Translational Medicine in Minneapolis, MN, a nonclinical laboratory, revealed significant deficiencies in their study conduct and record-keeping practices. The firm failed to adequately document study data, adhere to approved protocols, establish necessary standard operating procedures, maintain a comprehensive master schedule, and properly archive study records. These issues indicate a lack of robust quality control and data integrity.

## Related Officers

- [investigator](https://www.keypedia.com/people/chelsea-w-lamm/d7a8dd67-dc26-4c8a-8e3c-aebc267cb775)

Company: https://www.keypedia.com/companies/center-for-translational-medicine/6affff72-5373-461f-9895-5e9f96e39346

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d